These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26448147)

  • 1. Muscle-Derived IL-6 Is Not Regulated by IL-1 during Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study.
    Nordmann TM; Seelig E; Timper K; Cordes M; Coslovsky M; Hanssen H; Schmidt-Trucksäss A; Donath MY
    PLoS One; 2015; 10(10):e0139662. PubMed ID: 26448147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
    Larsen CM; Faulenbach M; Vaag A; Vølund A; Ehses JA; Seifert B; Mandrup-Poulsen T; Donath MY
    N Engl J Med; 2007 Apr; 356(15):1517-26. PubMed ID: 17429083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance.
    van Poppel PC; van Asseldonk EJ; Holst JJ; Vilsbøll T; Netea MG; Tack CJ
    Diabetes Obes Metab; 2014 Dec; 16(12):1269-73. PubMed ID: 25039318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 receptor antagonism and muscle gene expression in patients with type 2 diabetes.
    Berchtold LA; Larsen CM; Vaag A; Faulenbach M; Workman CT; Kruhøffer M; Donath M; Mandrup-Poulsen T
    Eur Cytokine Netw; 2009 Jun; 20(2):81-7. PubMed ID: 19541594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study.
    van Asseldonk EJ; Stienstra R; Koenen TB; Joosten LA; Netea MG; Tack CJ
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2119-26. PubMed ID: 21508140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
    Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
    Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra.
    Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Dasou P; Parissis J; Nikolaou M; Markantonis SL; Katsimbri P; Skarantavos G; Andreadou I; Anastasiou-Nana M
    Thromb Haemost; 2011 Nov; 106(5):959-67. PubMed ID: 21947196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ascorbic acid on microcirculation in patients with Type II diabetes: a randomized placebo-controlled cross-over study.
    Lu Q; Björkhem I; Wretlind B; Diczfalusy U; Henriksson P; Freyschuss A
    Clin Sci (Lond); 2005 Jun; 108(6):507-13. PubMed ID: 15675894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I.
    Böni-Schnetzler M; Boller S; Debray S; Bouzakri K; Meier DT; Prazak R; Kerr-Conte J; Pattou F; Ehses JA; Schuit FC; Donath MY
    Endocrinology; 2009 Dec; 150(12):5218-29. PubMed ID: 19819943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.
    Larsen CM; Faulenbach M; Vaag A; Ehses JA; Donath MY; Mandrup-Poulsen T
    Diabetes Care; 2009 Sep; 32(9):1663-8. PubMed ID: 19542207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IL-18 and hsCRP correlate with insulin resistance without effect of calcitriol treatment on type 2 diabetes.
    Akbarzadeh M; Eftekhari MH; Dabbaghmanesh MH; Hasanzadeh J; Bakhshayeshkaram M
    Iran J Immunol; 2013 Sep; 10(3):167-76. PubMed ID: 24076594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein.
    Hartmann G; Tschöp M; Fischer R; Bidlingmaier C; Riepl R; Tschöp K; Hautmann H; Endres S; Toepfer M
    Cytokine; 2000 Mar; 12(3):246-52. PubMed ID: 10704252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus.
    Donath MY; Mandrup-Poulsen T
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):240-1. PubMed ID: 18317479
    [No Abstract]   [Full Text] [Related]  

  • 14. IL-1β receptor antagonist reduces inflammation in hemodialysis patients.
    Hung AM; Ellis CD; Shintani A; Booker C; Ikizler TA
    J Am Soc Nephrol; 2011 Mar; 22(3):437-42. PubMed ID: 21310819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise increases pancreatic β-cell viability in a model of type 1 diabetes through IL-6 signaling.
    Paula FM; Leite NC; Vanzela EC; Kurauti MA; Freitas-Dias R; Carneiro EM; Boschero AC; Zoppi CC
    FASEB J; 2015 May; 29(5):1805-16. PubMed ID: 25609426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine supplementation further enhances exercise-induced plasma IL-6.
    Hiscock N; Petersen EW; Krzywkowski K; Boza J; Halkjaer-Kristensen J; Pedersen BK
    J Appl Physiol (1985); 2003 Jul; 95(1):145-8. PubMed ID: 12611772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of acute effect of light-emitting diode (LED) phototherapy on muscle deoxygenation and pulmonary oxygen uptake kinetics in patients with diabetes mellitus: study protocol for a randomized controlled trial.
    Francisco Cde O; Beltrame T; Ferraresi C; Parizotto NA; Bagnato VS; Borghi Silva A; Benze BG; Porta A; Catai AM
    Trials; 2015 Dec; 16():572. PubMed ID: 26666374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6.
    Dauriz M; Trombetta M; Boselli L; Santi L; Brangani C; Pichiri I; Bonora E; Bonadonna RC
    Acta Diabetol; 2016 Jun; 53(3):393-402. PubMed ID: 26538364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dietary supplement attenuates IL-6 and CRP after eccentric exercise in untrained males.
    Phillips T; Childs AC; Dreon DM; Phinney S; Leeuwenburgh C
    Med Sci Sports Exerc; 2003 Dec; 35(12):2032-7. PubMed ID: 14652498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the Effect of Physiological Concentrations of IL-6 on Insulin Secretion by INS-1 832/3 Insulinoma Cells under Diabetic-Like Conditions.
    Barlow J; Carter S; Solomon TPJ
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.